drugset / Trial / NCT00410735

Study of ONO-1078 in Patients With Chronic Sinusitis

NCT00410735

Phase 3 Completed 495 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the efficacy and safety of ONO-1078 in patients with chronic sinusitis in a double-blind, randomized, placebo-controlled, parallel group, multi-center study

Timeline

Start
2006-12
Primary completion
2008-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pranlukast Small molecule 225 mg